Security key
86150R107
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)
CUSIP: 86150R107
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 58,810,778
- Total 13F shares
- 66,984,195
- Share change
- +1,536,191
- Total reported value
- $2,126,072,755
- Put/Call ratio
- 8.1%
- Price per share
- $31.74
- Number of holders
- 183
- Value change
- +$58,211,085
- Number of buys
- 96
- Number of sells
- 70
Report period
Q4 2025
Institutions
183
Top holders
10
STOK full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 86150R107
Recent filing periods:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
|
Company |
9.8%
|
5,600,920
|
$177,773,201 | -$40,123,708 | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
6.8%
from 13D/G
|
5,987,441
|
$140,704,869 | — | 30 Sep 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
8.7%
|
5,123,525
|
$120,402,838 | — | 30 Sep 2025 | |
| Lynx1 Capital Management LP |
13F
|
Company |
9.2%
|
5,404,674
|
$109,881,253 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13F
13D/G
|
Company |
5.8%
from 13D/G
|
4,633,838
|
$108,895,193 | — | 30 Sep 2025 | |
| Redmile Group, LLC |
13F
|
Company |
7.1%
|
4,175,542
|
$98,125,237 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
3,537,050
|
$83,120,676 | — | 30 Sep 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
5.4%
|
3,173,258
|
$74,571,563 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.4%
|
3,163,874
|
$74,351,040 | — | 30 Sep 2025 | |
| Skorpios Trust |
13F
13D/G
3/4/5
|
Company · Montrago Trustees Ltd · 10%+ Owner |
4.1%
from 13D/G
|
2,256,181
|
$53,020,254 | — | 30 Sep 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
3.8%
|
2,247,347
|
$52,812,655 | — | 30 Sep 2025 | |
| BVF INC/IL |
13F
|
Company |
2.8%
|
1,657,096
|
$38,941,756 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
1,425,873
|
$33,508,016 | — | 30 Sep 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.3%
|
1,323,470
|
$31,101,545 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.2%
|
1,306,698
|
$30,707,403 | — | 30 Sep 2025 | |
| BlackRock Portfolio Management LLC |
13D/G
|
— |
4.7%
|
2,550,341
|
$28,946,115 | -$2,192,358 | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
1,150,929
|
$27,046,832 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,147,000
|
$26,959,632 | — | 30 Sep 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
1.6%
|
915,785
|
$21,521,000 | — | 30 Sep 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.5%
|
900,272
|
$21,156,392 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.3%
|
789,698
|
$18,557,903 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.3%
|
768,287
|
$18,054,745 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.3%
|
737,753
|
$17,337,197 | — | 30 Sep 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
1.2%
|
682,017
|
$16,027,400 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
678,307
|
$15,946,030 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.85%
|
500,000
|
$11,750,000 | — | 30 Sep 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.67%
|
396,000
|
$9,793,080 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.71%
|
414,917
|
$9,750,551 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.69%
|
402,909
|
$9,468,362 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.57%
|
334,481
|
$7,860,021 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.52%
|
306,037
|
$7,191,870 | — | 30 Sep 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.43%
|
253,899
|
$5,966,626 | — | 30 Sep 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.43%
|
250,000
|
$5,875,000 | — | 30 Sep 2025 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.43%
|
250,000
|
$5,875,000 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.42%
|
249,451
|
$5,862,098 | — | 30 Sep 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.4%
|
238,015
|
$5,593,351 | — | 30 Sep 2025 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.36%
|
212,049
|
$4,983,152 | — | 30 Sep 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.36%
|
210,000
|
$4,935,000 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.35%
|
208,075
|
$4,889,763 | — | 30 Sep 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.29%
|
169,791
|
$3,990,089 | — | 30 Sep 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.26%
|
155,166
|
$3,646,401 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.26%
|
152,299
|
$3,579,026 | — | 30 Sep 2025 | |
| Penserra Capital Management LLC |
13F
|
Company |
0.26%
|
150,599
|
$3,539,000 | — | 30 Sep 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.21%
|
126,350
|
$2,969,225 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
120,436
|
$2,830,247 | — | 30 Sep 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.2%
|
120,181
|
$2,778,565 | — | 30 Sep 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.2%
|
115,833
|
$2,722,077 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.18%
|
107,723
|
$2,531,492 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.18%
|
105,994
|
$2,490,860 | — | 30 Sep 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.18%
|
105,427
|
$2,477,535 | — | 30 Sep 2025 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q4 2025
As of 31 Dec 2025,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
183 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,984,195 shares.
The largest 10 holders included
FMR LLC, RTW INVESTMENTS, LP, Lynx1 Capital Management LP, BlackRock, Inc., Redmile Group, LLC, MORGAN STANLEY, BAKER BROS. ADVISORS LP, TORONTO DOMINION BANK, VANGUARD GROUP INC, and STATE STREET CORP.
This page lists
183
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
151
Q4 2025 holders
183
Holder diff
32
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.